Tenax Therapeutics

NEWS
SIFI, BeiGene and Novo Holdings shared promising updates on their proposed treatments for acanthamoeba keratitis, relapsed or refractory CCL and myasthenia gravis.
Biopharma and life sciences companies strengthen their boards and leadership teams with these Movers & Shakers.
Scorpion Therapeutics announced its new CEO Dr. Axel Hoos while Tenax Therapeutics named Christopher Giordano as its new chief executive.
IN THE PRESS
JOBS